Table 2. Predicted prognostic value of FANCI in LUAD.
| Clinicopathological features | Subgroup | Univariate analyses | Multivariate analyses | |||||
|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | |||
| Gender | Male | 1.00 | 0.67–1.21 | 0.49 | ||||
| Female | 0.90 | |||||||
| Age (years) | <60 | 1.00 | 0.76–1.48 | 0.75 | ||||
| ≥60 | 1.06 | |||||||
| Tumor size (cm) | <3 | 1.00 | 1.20–2.40 | 0.003** | 1.00 | 0.93–1.91 | 0.115 | |
| ≥3 | 1.70 | 1.33 | ||||||
| Lymphatic metastasis | N0 | 1.00 | 1.83–3.32 | 0.000** | 1.00 | 1.63–3.01 | 0.000** | |
| N1–N3 | 2.64 | 2.22 | ||||||
| Distant metastasis | M0 | 1.00 | 1.10–3.42 | 0.022* | 1.00 | 0.94–2.94 | 0.081 | |
| M1 | 1.94 | 1.66 | ||||||
| FANCI expression | Low | 1.00 | 1.19–2.18 | 0.002** | 1.00 | 1.02–1.89 | 0.039* | |
| High | 1.61 | 1.39 | ||||||
*P<0.05; **P<0.01. LUAD, lung adenocarcinoma.